Cargando…

Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()

The enzyme-linked immunosorbent assay (ELISA) was used to determine levels of specific IgG antibodies against measles, rubella, vaccinia, corona (OC43) and mumps viruses in cerebrospinal fluid (CSF) and serum of 18 patients with clinically definite multiple sclerosis (MS), 8 patients with optic neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Leinikki, Pauli, Shekarchi, Isabel, Iivanainen, Matti, Taskinen, Eero, Holmes, Kathryn V., Madden, David, Sever, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127299/
https://www.ncbi.nlm.nih.gov/pubmed/6298370
http://dx.doi.org/10.1016/0022-510X(82)90031-4
_version_ 1783516329839427584
author Leinikki, Pauli
Shekarchi, Isabel
Iivanainen, Matti
Taskinen, Eero
Holmes, Kathryn V.
Madden, David
Sever, John L.
author_facet Leinikki, Pauli
Shekarchi, Isabel
Iivanainen, Matti
Taskinen, Eero
Holmes, Kathryn V.
Madden, David
Sever, John L.
author_sort Leinikki, Pauli
collection PubMed
description The enzyme-linked immunosorbent assay (ELISA) was used to determine levels of specific IgG antibodies against measles, rubella, vaccinia, corona (OC43) and mumps viruses in cerebrospinal fluid (CSF) and serum of 18 patients with clinically definite multiple sclerosis (MS), 8 patients with optic neuritis (ON), 27 patients with other neurological disease (OND), and 88 control subjects without central nervous system disease. Serum antibody levels were not significantly different between the four groups. Differences in the frequency and levels of CSF antibodies between the four groups were observed. Control patients had serumCSF antibody ratios from 2.0 to 3.0 (log) with an average of 2.5 corresponding to a 320-fold difference between serum and CSF antibody levels. MS patients had ratios from 1.1 to 2.1 with an average of 1.6. The average was 2.0 for the ON patients. The average for the OND patients was similar to the controls. The altered serumCSF ratios for several viruses within an individual patient was similar. These results suggest that nonspecific immunostimulation is responsible for the increased levels of CSF virus antibodies.
format Online
Article
Text
id pubmed-7127299
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71272992020-04-08 Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests() Leinikki, Pauli Shekarchi, Isabel Iivanainen, Matti Taskinen, Eero Holmes, Kathryn V. Madden, David Sever, John L. J Neurol Sci Article The enzyme-linked immunosorbent assay (ELISA) was used to determine levels of specific IgG antibodies against measles, rubella, vaccinia, corona (OC43) and mumps viruses in cerebrospinal fluid (CSF) and serum of 18 patients with clinically definite multiple sclerosis (MS), 8 patients with optic neuritis (ON), 27 patients with other neurological disease (OND), and 88 control subjects without central nervous system disease. Serum antibody levels were not significantly different between the four groups. Differences in the frequency and levels of CSF antibodies between the four groups were observed. Control patients had serumCSF antibody ratios from 2.0 to 3.0 (log) with an average of 2.5 corresponding to a 320-fold difference between serum and CSF antibody levels. MS patients had ratios from 1.1 to 2.1 with an average of 1.6. The average was 2.0 for the ON patients. The average for the OND patients was similar to the controls. The altered serumCSF ratios for several viruses within an individual patient was similar. These results suggest that nonspecific immunostimulation is responsible for the increased levels of CSF virus antibodies. Published by Elsevier B.V. 1982-12 2003-03-18 /pmc/articles/PMC7127299/ /pubmed/6298370 http://dx.doi.org/10.1016/0022-510X(82)90031-4 Text en Copyright © 1982 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Leinikki, Pauli
Shekarchi, Isabel
Iivanainen, Matti
Taskinen, Eero
Holmes, Kathryn V.
Madden, David
Sever, John L.
Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title_full Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title_fullStr Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title_full_unstemmed Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title_short Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests()
title_sort virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with elisa tests()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127299/
https://www.ncbi.nlm.nih.gov/pubmed/6298370
http://dx.doi.org/10.1016/0022-510X(82)90031-4
work_keys_str_mv AT leinikkipauli virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT shekarchiisabel virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT iivanainenmatti virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT taskineneero virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT holmeskathrynv virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT maddendavid virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests
AT severjohnl virusantibodiesinthecerebrospinalfluidofmultiplesclerosispatientsdetectedwithelisatests